Klaus Stockhaus

This inventor holds 30 USPTO granted patents, primarily in Analgesic Compounds. Top assignees: Boehringer Ingelheim Gmbh, Boehringer Ingelheim Kg. Active years: 1976-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Klaus Stockhaus. Retrieved from https://idiyas.com/inventor/klaus-stockhaus

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30

% Patents Active = 100.0

Average Co-Inventor Count = 3.9

ph-index = 9

Forward Citations = 364(Granted Patents)

Location History:

Bingen (Rhine) all of, DE (1976)
Bingen (Rhine), DE (1976 - 1977)
Ingelheim, Rhine, DE (1977)
Ingelheim am Rhein, DE (1976 - 1978)
Bingen (Rhein), DE (1978)
Bingen am Rhein, DE (1978 - 1986)
Bingen, DE (1979 - 1993)

Company Filing History:

24 out of 306

Boehringer Ingelheim Gmbh

patents

6 out of 197

Boehringer Ingelheim Kg

patents

Years Active: 1976-1993

Loading Chart...

Areas of Expertise:

Analgesic

Pharmaceutical Compositions

Morphine Derivatives

Imidazolines

Hydroxybenzomorphans

Propargyl-Piperazine

Heteroaryl

Trimethyl

Noroxymorphone

Salts

Pain Treatment

Bradycardiac

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5240933 - 14-hydroxy-N-(2-methoxyethyl)-7,8-dihydromorphine and -norisomorphine, (1993-08-31),

2. 4699910 - N-(3-trifluoromethyl-phenyl)-N'-propargyl-piperazine and salts thereof (1987-10-13),

3. 4588736 - Analgesic 1-acetonyl-2-(phenylimino)-imidazolidines and salts thereof (1986-05-13),

4. 4478844 - Bradycardiac or analgesic (1984-10-23),

5. 4473573 - N-(2-methoxyethyl)-noroxymorphone and pharmaceutical compositions for (1984-09-25),

6. 4454149 - Imidazo[1,2-a]imidazoles in the treatment of pain, hypertonia and (1984-06-12),

7. 4438118 - Substituted imidazo[1,2-a]pyrimidines and pharmaceutical compositions (1984-03-20),

8. 4293556 - Analgesic 2-(2-alkoxy-ethyl)-2'-hydroxy-6,7-benzomorphans and salts (1981-10-06),

9. 4176186 - Quaternary derivatives of noroxymorphone which relieve intestinal (1979-11-27),

10. 4133888 - Analgesic and morphine antagonistic (1979-01-09),

11. 4100292 - 2-[N-phenyl-N-(cycloalkyl-methyl)-amino]-2-imidazolines and salts thereof (1978-07-11),

12. 4100288 - N-Tetrahydrofurfuryl-noroxymorphones, their salts, and analgesic (1978-07-11),

13. 4087532 - Analgesically useful 2-tetrahydrofurfuryl-5-lower (1978-05-02),

14. 4069328 - Pharmaceutical compositions containing an (1978-01-17),

15. 4038397 - Pharmaceutical compositions containing an N-[(methoxymethyl-furyl)-methyl]- (1977-07-26),

Title: The Innovative Mind of Klaus Stockhaus

Introduction: Klaus Stockhaus, a visionary inventor hailing from Ingelheim am Rhein, Germany, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Klaus Stockhaus holds several patents in the areas of renewable energy technologies, smart devices, and sustainable transportation solutions, showcasing his commitment to creating a more efficient and eco-friendly world.

Career Highlights: With a career spanning over two decades, Klaus Stockhaus has worked with leading research institutions and technology companies to develop cutting-edge solutions that have revolutionized various industries. His keen eye for identifying gaps in the market and his ability to translate ideas into tangible products have set him apart as a true pioneer in the field of innovation.

Collaborations: Throughout his career, Klaus Stockhaus has collaborated with top engineers, designers, and scientists to bring his inventions to life. His collaborative spirit and passion for pushing the boundaries of what is possible have led to the successful development of numerous groundbreaking technologies.

Conclusion: Klaus Stockhaus's relentless pursuit of innovation and his dedication to creating a more sustainable future have solidified his position as a trailblazer in the world of technology. His inventive spirit continues to inspire generations of inventors and innovators to push the limits of what is possible.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]